Program for October 23 (Thu), Day 1/JDDW 2014 - KOBE
Oral presentation schedule for October 23 (Thu), Day 1
    Kobe International Exhibition Hall No.2 Building Portopia Hotel Kobe International Conference Center Kobe International Exhibition Hall No.1 Building Kobe International Exhibition Hall No.3 Building Portopia Hotel  
  Hall (North) Hall (South) Conference
Room 3A
Portopia Hall Ohwada A Ohwada B Ohwada C Kairaku 1+2 Kairaku 3 Waraku Topaz Main Hall International Conference Room Digital Poster Session & Commercial Exhibition Digital Poster Session & Commercial Exhibition Emerald  
  Room 1 Room 2 Room 3 Room 4 Room 5 Room 6 Room 7 Room 8 Room 9 Room 10 Room 11 Room 12 Room 13 Room 14 Room 15 Room 16  
8:00 8:00
40 No planned seminars No planned seminars

Breakfast
Seminar1

Astellas Pharma Inc./ Pfizer Japan Inc.
Basic Science and Evidence in Clinical Research of NSAID- associated GI Injuries
  No planned seminars

Breakfast
Seminar2

AJINOMOTO PHARMA CEUTICALS CO., LTD.
Progress in treatment of Chronic pancreatitis and New Guideline

Breakfast
Seminar3

Century Medical Inc.
Radio Frequency Ablation
–state-of-the-art technique–
No planned seminars No planned seminars No planned seminars No planned seminars No planned seminars

Breakfast
Seminar4

DAIICHI SANKYO CO., LTD./ Toray Industries, Inc.
New treatments and the future role of interferon-based therapy for hepatitis C
      40
45 Opening Ceremony 45
50                         50
9:00   9:00
40

S1 (JSH/JSGE)
Therapeutic strategies for prophylaxis and control of hepatitis B virus related hapatocellulrar carcinoma

Chair: O. Yokosuka
H. Yatsuhashi

S2 (JSGE/JGES/
JSGS)
What is an optimal treatment in initial stage of severe acute pancreatitis?

Chair: T. Shimosegawa
Y. Takeyama

W1 (JSGE/JGES/
JSGS)
Towards preservation and regeneration of defense mechanism in intestinal mucosa

Chair: K. Fujimoto
H. Imaeda

PD3 (JSGE/JGES)
GERD - Emerging problems in its research and clinical practice (controversies in GERD and its complications)

Chair: H. Goto
Y. Kinoshita

Invited Lecture (Keynote Lecture) (JSH)
Stemness and reprogramming in liver cancer

S. S. Thorgeirsson
Chair: G. Shiota
I. Sakaida

Invited Lecture (Keynote Lecture) (JSGE)
New perspectives in functional dyspepsia

J. Tack
Chair: H. Suzuki

S4 (JSH/JSGE)
Pathologic analysis and new therapeutic options for NAFLD/NASH

Chair: S. Watanabe
T. Saibara

S5 (JSGCS/JSGE/
JGES)
How should the Helicobacter pylori induced gastritis be managed in the gastric cancer screening?

Chair: D. Shibuya
T. Ambo
Live broadcast Room 1 Live broadcast Room 2 Live broadcast Room 3

PD5 (JSGE)
Gastrointestinal tract and cancer stem cells

Chair: T. Joh
T. Azuma

S7 (JSH/JSGE/
JSGS)
The biomarker investigation in patients with hepatocellular carcinoma for future clinical practice

Chair: E. Miyoshi
M. Sakamoto
 Commercial Exhibition  Commercial Exhibition Gastrointestinal and Pancreaticobiliary Endoscopy Live Seminar (JGES) 40
45

IS-S3 (JSGE)
Functional dyspepsia and its new perspective

Chair: H. Miwa
H. Suzuki
45
10:00

IS-S1 (JSH/JSGE/
JSGS)
Stem cells in liver regeneration and therapy: Present and future scope

Chair: G. Shiota
I. Sakaida
10:00
11:00     11:00
20     20
30

Special Lecture (JSGE)
Grand challenge in life science on Supercomputer K

R. Himeno
Chair: S. Miura
30
12:00

Lecture by Congress President (JSGCS)
Gastrointestinal cancer screening in the near future

K. Inoue
Chair: A. Fukao
12:00
30                                 30
13:00 Academic Council (Japanese Society of Gastroenterology)
12:30-13:40

Luncheon
Seminar28

Bristol-Myers Squibb
The 5th Bristol–Myers Award Ceremony
The final stage of hepatitis C treatment
–The treatment strategy with a new interferon-free oral dual regimen–

Luncheon
Seminar29

HOYA Corporation
The New Prospect of ESD with OE
No planned seminars

Luncheon
Seminar30

MSD K.K.
The 13th MSD Award Ceremony
Newly triple therapy for chronic hepatitis C

Luncheon
Seminar31

Astellas Pharma Inc./ ZERIA Pharmaceutical Co., Ltd.
Pathophysiology and management of functional dyspepsia
–Introduction of FD guideline and key points of pharmacological treatment–

Luncheon
Seminar32

Sysmex Corporation
The development strategy of glycobiomarkers for accurate disease assessment
–A case of hepatic fibrosis marker–

Luncheon
Seminar33

Otsuka Pharmaceutical Co., Ltd.
Population-based screening of gastric cancer in Helicobacter pylori era. – A new framework of gastric cancer screening focusing on high-risk population and follow-ups after eradication.–

Luncheon
Seminar34

Bayer Yakuhin, Ltd.
Diagnosis and Treatment of HCC:UP-TO-DATE

Luncheon
Seminar35

Eisai Co., Ltd.

Luncheon
Seminar36

NIPPON SHINYAKU CO., LTD
Alcohol-related organ damage and effect of abstinence

Luncheon
Seminar37

JIMRO Co., Ltd.
Optimization of GMA therapy in patients with IBD

Luncheon
Seminar38

AJINOMOTO PHARMA CEUTICALS CO., LTD.
The16th AJINOMOTO Award Ceremony
Diabetes and liver cancer: tips in clinical practice
13:00
40       40
14:00                           14:00
30

PD1 (JSH/JSGE)
New trends and goal of hepatitis C therapy

Chair: N. Izumi
K. Chayama

PD2 (JSGE/JGES/
JSGS)
Gastrointestinal bleeding and effective measures against it in the elderly

Chair: C. Sakamoto
I. Hirata

Invited Lecture (JSGCS)
Results of a colorectal cancer screening program in Brazil

C. R. Teixeira
Chair: K. Haruma

S3 (JSGE/JGES/
JSGS)
Intractable Crohn's disease: Therapeutic approaches based on its pathophysiology

Chair: Y. Kohgo
M. Watanabe

Invited Lecture (Keynote Lecture) (JSH)
Progress and challenges in hepatic fibrosis

S. L. Friedman
Chair: N. Kawada
H. Yoshiji

L-IS1 (JSGE)
International panel discussion with Asian Pacific GI leaders 'Current clinical trend and future of GI disorders in Asian-Pacific region'

K. M. Fock
K.-L. Goh
Y.-Q. Li
J.-T. Lin
U. Kachintorn
J.-G. Kim
M. Simadibrata
S. P. Singh
Chair: K. Sugano
K.-L. Goh

PD4 (JSH/JSGE/
JGES/JSGS)
Pathologic analysis and treatment options of autoimmune hepato-biliary diseases

Chair: M. Zeniya
H. Ohira

S6 (JSGCS/JSGE/
JGES)
The present situation and problem of risk assessment for gastric cancer

Chair: M. Yoshihara
T. Kamada
Live broadcast Room 1 Live broadcast Room 2 Live broadcast Room 3

Special Lecture (JSGE)
Impact of immunogenomics and immunopharmacogenomics in medical science in the 21st century

Y. Nakamura
Chair: K. Yamamoto

W3 (JSH/JSGE/
JSGS)
Acute liver failure: Future prospects of novel treatment options for better prognosis

Chair: S. Mochida
A. Ido
Digital Poster Session
(JSGE)
14:00-16:30
Digital Poster Session
(JSH)
14:00-16:30
Gastrointestinal and Pancreaticobiliary Endoscopy Live Seminar (JGES) 30
45

W2 (JSGCS/JSGE/
JGES)
Evaluation of CT colonography as diagnostic examination in
colorectal cancer screening

Chair: R. Nozaki
T. Shimada
45
15:00

IS-S2 (JSH/JSGE)
Mechanisms of hepatic and pancreatic fibrosis ; Clinical implications

Chair: N. Kawada
H. Yoshiji

PD6 (JSGE/JSGS)
Novel therapeutic strategy for pancreatic and bile duct cancer based on molecular targeting and anti-tumor immunity

Chair: K. Yamamoto
H. Ohnishi
15:00
16:00 16:00
30 30
17:00     17:00
30                                 30
18:00 No planned seminars No planned seminars

Satellite
Symposium72

TAIHO PHARMACEUTICAL CO. LTD
Esophageal Function and GERD Treatment in Japanese Patients
No planned seminars

Satellite
Symposium73

Janssen Pharmaceutical K.K.

Satellite
Symposium74

Sumitomo Dainippon Pharma Co., Ltd.
Treatment strategy of the chronic liver disease –Unsolved problem in hepatitis treatment–

Satellite
Symposium75

FUJIFILM Medical Co., Ltd.
Novel Evolution of Trans-nasal Endoscopy

Satellite
Symposium76

MSD K.K.
Expanding the possibility of IFN containing therapy

Satellite
Symposium77

Wako Pure Chemical Industries, Ltd.
The role of Gastric cancer risk classification (ABC classification) in the era of primary gastric cancer prevention

Satellite
Symposium78

KYORIN PHARMACEUTICAL CO., LTD
How do you maximize the value of PENATSA family?

Satellite
Symposium79

EIKEN CHEMICAL CO., LTD.
Colorectal Cancer Screening Now and Future
–To Reduce The Mortality of Colorectal Cancer

Satellite
Symposium80

ZERIA Pharmaceutical Co., Ltd./ Kyowa Hakko Kirin Co., Ltd.
Verification of endoscopic indices and definition of mucosal healing in ulcerative colitis –Focus on in-depth discussion between domestic and international IBD experts–
Western District Council (Japan Society of Hepatology)
17:30-18:30
18:00
30       30
40       40
19:00   19:00
30                     30
20:00             20:00
                                 

Copyright © JDDW 2014. All Rights Reserved.